Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
about
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococciSystematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremiaInfluence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs PatientsIntrinsic and acquired resistance mechanisms in enterococcus.Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapyRisk factors associated with linezolid-nonsusceptible enterococcal infections.Multicenter study of high-dose daptomycin for treatment of enterococcal infectionsSystematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis.Vancomycin-resistant enterococcal meningitis in an autologous stem cell transplant recipient cured with linezolid.Current and prospective treatments for multidrug-resistant gram-positive infections.Antibiotic resistance in Enterococcus faecium clinical isolates.Vancomycin-resistant enterococcal bacteremia pharmacotherapy.Therapeutic options for vancomycin-resistant enterococcal bacteremia.Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012).Enterococcal bloodstream infection. Design and validation of a mortality prediction rule.Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay usiEvaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.Clinical, epidemiological, and microbiological profile of patients with vancomycin-resistant enterococci from a tertiary care hospitalEndocarditis caused by resistant enterococcus: an overview.Pharmacokinetic/pharmacodynamic (PK/PD) Determinants of Vancomycin Efficacy in Enterococcal Bacteremia.Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.Linezolid: a review of its properties, function, and use in critical care.
P2860
Q26851754-2666C1A8-E39B-4A5F-9515-BB7E2D90334CQ28302184-68B0F6DB-39E3-4A98-889F-4285C2BF88D9Q30277034-9E74F6DE-07EA-4D7D-A33F-C4DA6FA1E53FQ33798444-0DD39624-DCD6-408D-9277-6F1126EA4C5BQ34503844-7C1305C4-44EE-44C0-84E0-1D670C557825Q34728711-BE91ADC2-F0EA-45D8-84F6-D1DEF1C9F8B3Q34871254-6EC5916B-18CC-45F6-B001-48DDBE332C68Q35999714-D0A4583F-DDB2-414A-8F2F-F8CD9255F8B6Q36362547-9C39D5E3-9626-48F7-B438-7AA140A2E6E6Q36505376-0C146222-B05F-458C-B219-D2B4033C7DC0Q36818367-13CDDFCD-17FB-4F0B-A194-905A123C319BQ37124177-4622C63A-D008-4EFB-8998-201015A85DE9Q37263709-F31BCD7B-607F-44BE-B345-9C6E46AC21A7Q37335865-AA080A47-AABD-475D-B99D-4EB60A73EE44Q38061694-1CAEF58B-5F15-4A54-A9E9-E9CD7336B35EQ38123255-2FC26F50-8A08-4D80-BE25-2BD548E40E46Q38176042-8700D68D-35C8-4DB1-A9FB-0F5FEAAF4C3AQ38263421-669AF1B8-35B5-4AB4-8C41-BF1854713928Q38347869-68649F7A-5F60-4980-BA9C-568F51C10876Q39683665-F96B46D8-B04C-4EF9-BB21-80209BAB7290Q40053444-EF0DAD82-1951-44D1-8169-7482CBB9D886Q40306161-C2F3B1A7-3DF8-414B-BFD7-70EDE6B69E9CQ41696975-6016838C-A650-4621-843E-6E280AA5BABBQ42003344-4775B538-55AF-46DF-9DBE-ADC7BE1A7A5FQ42189998-7D056315-E8AC-4CB1-9606-C923BF9AC14EQ42217963-FEC7FDAB-6754-4B38-9677-1AF891F72610Q42259672-1084C0FE-AD30-472E-B54A-E3B467E9DC4DQ47273967-2CD604BD-930B-43FA-BCE5-03D8CB26D3B1Q50943146-5D9154AC-637B-4A38-9BB3-E471F57587A7Q55368160-C74A91B0-C134-4ADB-B8BE-C3A96776F355
P2860
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of outcomes from da ...... ve, multicenter, cohort study.
@en
Comparison of outcomes from da ...... ve, multicenter, cohort study.
@nl
type
label
Comparison of outcomes from da ...... ve, multicenter, cohort study.
@en
Comparison of outcomes from da ...... ve, multicenter, cohort study.
@nl
prefLabel
Comparison of outcomes from da ...... ve, multicenter, cohort study.
@en
Comparison of outcomes from da ...... ve, multicenter, cohort study.
@nl
P2093
P1476
Comparison of outcomes from da ...... ve, multicenter, cohort study.
@en
P2093
Benjamin Brielmaier
Christopher W Crank
David J Ritchie
Gourang P Patel
John Segreti
Warren E Rose
P304
P356
10.1016/J.CLINTHERA.2010.09.008
P577
2010-09-01T00:00:00Z